Progyny Q1 revenue $324M (+16.5% YoY), raises FY2025 guidance above prior outlook

Progyny, Inc.

2025-Q1 EPS reported $0.17 revenue$324,038,000

Q1 revenue $324.0M (+16.5% YoY); gross margin 23.4% vs 22.4% a year ago.
Adjusted EBITDA $57.8M (17.8% margin) vs $50.3M (18.1% margin) in Q1 2024.
Net income $15.1M ($0.17 EPS); adjusted EPS $0.48 vs $0.39 in prior year.
FY2025 revenue guidance raised to $1.185B-$1.235B; adjusted EBITDA guided $190M-$203M.
Fertility clients 532 (up from 451); ART cycles 16,160 (+9.2% YoY). Large client transition contributed $31.3M revenue in Q1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.